|
| |
| | | 57362 | | 16.03.2007 | | Mepha Pharma AG | | 17.01.2008 | | | | | | | | | | | 01.01.30. | | | | 01.01.30. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Fentanyl-Mepha 25 | transdermale Pflaster | Matrixpflaster (Fentanyl 4.125 mg) | N02AB03 | PI | | 02 | Fentanyl-Mepha 50 | transdermale Pflaster | Matrixpflaster (Fentanyl 8.25 mg) | N02AB03 | PI | | 03 | Fentanyl-Mepha 75 | transdermale Pflaster | Matrixpflaster (Fentanyl 12.375 mg) | N02AB03 | PI | | 04 | Fentanyl-Mepha 100 | transdermale Pflaster | Matrixpflaster (Fentanyl 16.5 mg) | N02AB03 | PI | | 05 | Fentanyl-Mepha 12 | transdermale Pflaster | Matrixpflaster (Fentanyl 2.063 mg) | N02AB03 | PI |
|
|
|
